SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-028440
Filing Date
2022-08-08
Accepted
2022-08-08 16:08:40
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q stok-10q_20220630.htm   iXBRL 10-Q 2447900
2 EX-10.1 stok-ex101_241.htm EX-10.1 155160
3 EX-31.1 stok-ex311_7.htm EX-31.1 18395
4 EX-31.2 stok-ex312_6.htm EX-31.2 18292
5 EX-32.1 stok-ex321_9.htm EX-32.1 7195
6 EX-32.2 stok-ex322_8.htm EX-32.2 7870
  Complete submission text file 0001564590-22-028440.txt   7222050

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA stok-20220630.xsd EX-101.SCH 45652
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE stok-20220630_cal.xml EX-101.CAL 42840
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE stok-20220630_def.xml EX-101.DEF 91695
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE stok-20220630_lab.xml EX-101.LAB 302166
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stok-20220630_pre.xml EX-101.PRE 215098
55 EXTRACTED XBRL INSTANCE DOCUMENT stok-10q_20220630_htm.xml XML 1153915
Mailing Address 45 WIGGINS AVENUE BEDFORD MA 01730
Business Address 45 WIGGINS AVENUE BEDFORD MA 01730 781-430-8200
Stoke Therapeutics, Inc. (Filer) CIK: 0001623526 (see all company filings)

IRS No.: 471144582 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38938 | Film No.: 221144413
SIC: 2834 Pharmaceutical Preparations